What is ImaCor?
ImaCor, Inc. is a specialized technology firm focused on the design, manufacturing, and distribution of hTEE (Hemodynamic Transesophageal Echocardiography) technology. This advanced system is engineered to empower clinicians in precisely optimizing cardiac performance throughout a patient's treatment continuum. The company's innovative approach addresses critical needs in cardiac care, positioning it as a key player in the medical device and healthcare technology sector.
How much funding has ImaCor raised?
ImaCor has raised a total of $5.5M across 2 funding rounds:
Series A
$5.5M
Debt
$79K
Series A (2009): $5.5M with participation from WFD VENTURES
Debt (2021): $79K led by PPP
Key Investors in ImaCor
WFD VENTURES
WFD Ventures LLC is an investment firm that specializes in providing equity financing and industry expertise to companies within the medical device and healthcare technology sectors. They actively seek partnerships with innovators to enhance medical outcomes and maximize financial potential.
What's next for ImaCor?
With the recent influx of substantial expansion capital, ImaCor is poised for significant scaling and further technological advancement. The company's strategic focus will likely involve broadening its market reach, enhancing its hTEE technology, and potentially exploring new clinical applications. This major enterprise-level funding suggests a strong investor confidence in ImaCor's business model and its potential for future profitability and market leadership in cardiac performance optimization.
See full ImaCor company page
